Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity

Journal of Nuclear Medicine

Volumn 50, Issue 9, 2009, Pages 1479-1482

  Goldstein, David S ^a   Holmes, Courtney ^a   Sewell, LaToya ^a   Kopin, Irwin J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Fluorodopa; Orthostatic hypotension; Parkinson; Pure autonomic failure; Supine hypertension

Indexed keywords

6 FLUORODOPA F 18; FLUDROCORTISONE; LEVODOPA; MIDODRINE;

ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DRUG BLOOD LEVEL; DRUG UPTAKE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OCCIPITAL CORTEX; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RADIOACTIVITY; SUPINE POSITION; SYSTOLIC BLOOD PRESSURE;

AGED; BRAIN; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PARKINSON DISEASE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 69449089428     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.062869     Document Type: Article

References (19)

1. Leenders KL, Palmer AJ, Quinn N, et al. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry. 1986;49:853-860. (Pubitemid 16048411)
2. Garnett ES, Firnau G, Nahmias C. Dopamine visualized in the basal ganglia of living man. Nature. 1983;305:137-138. (Pubitemid 14235666)
3. Nahmias C, Garnett ES, Firnau G, Lang A. Striatal dopamine distribution in parkinsonian patients during life. J Neurol Sci. 1985;69:223-230. (Pubitemid 15074618)
4. 18F]- fluorodopa positron emission tomography scans. Ann Neurol. 1990;28:592-593.
5. Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin. 2002;20:291-301. (Pubitemid 34803330)
6. Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42:136-142. (Pubitemid 36944586)
7. Goldstein DS, Holmes C, Dendi R, Bruce S, Li S-T. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology. 2002;58:1247-1255. (Pubitemid 34411870)
8. Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Arch Neurol. 1984;41:612-614. (Pubitemid 14108767)
9. 18F-6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA. Front Biosci. 2004;9:505-512.
10. Arnold KG. Cerebral blood flow in geriatrics: a review. Age Ageing. 1981;10:5-9. (Pubitemid 11102821)
11. Levine BD, Giller CA, Lane LD, Buckey JC, Blomqvist CG. Cerebral versus systemic hemodynamics during graded orthostatic stress in humans. Circulation. 1994;90:298-306.
12. Levine BD, Zhang R. Comments on Point:Counterpoint: sympathetic activity does/does not influence cerebral blood flow - autonomic control of the cerebral circulation is most important for dynamic cerebral autoregulation. J Appl Physiol. 2008;105:1369-1373.
13. Strandgaard S, Sigurdsson ST. Point:Counterpoint: sympathetic activity does/ does not influence cerebral blood flow - counterpoint: sympathetic nerve activity does not influence cerebral blood flow. J Appl Physiol. 2008;105:1366-1367.
14. Novak V, Novak P, Spies JM, Low PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke. 1998;29:104-111. (Pubitemid 28046950)
15. Brooks DJ, Redmond S, Mathias CJ, Bannister R, Symon L. The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry. 1989;52:962-966. (Pubitemid 19220168)
16. Horowitz DR, Kaufmann H. Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure. Clin Auton Res. 2001;11:363-367. (Pubitemid 34461716)
17. Ogawa M, Fukuyama H, Harada K, Kimura J. Cerebral blood flow and metabolism in multiple system atrophy of the Shy-Drager syndrome type: a PET study. J Neurol Sci. 1998;158:173-179. (Pubitemid 28342081)
18. Matsubara S, Sawa Y, Yokoji H, Takamori M. Shy-Drager syndrome: effect of fludrocortisone and L-threo-3,4-dihydroxyphenylserine on the blood pressure and regional cerebral blood flow. J Neurol Neurosurg Psychiatry. 1990;53:994-997. (Pubitemid 20378904)
19. Sharabi Y, Imrich R, Holmes C, Pechnik S, Goldstein DS. Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson disease with orthostatic hypotension. Mov Disord. 2008;23:1725-1732.